Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
BioXcel Therapeutics, Inc.
New Haven, CT
We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 12, 2021, relating to the financial statements of BioXcel Therapeutics, Inc. appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.
/s/ BDO USA, LLP
Stamford, CT
August 16, 2022
